Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

My previous session
Most popular
Analysis summaryMarketScreener Strategies

Franck Morel

share with twitter share with LinkedIn share with facebook
share via e-mail

A technical turn-around configuration

Strategy published on 10/07/2016 | 14:32
long trade
Expirée le 10/22/2016
Entry price : 90.25€ | Target : 104€ | Stop-loss : 87.9€ | Potential : 15.24%
Bayer AG reflects attractive technical aspects that could allow investors to expect a trend reversal over the medium term.
Investors have an opportunity to buy the stock and target the € 104.
  • In a short-term perspective, the company has interesting fundamentals.

  • The share is getting closer to its long-term support in weekly data, at EUR 85.33, which offers good timing for buyers.
  • The close medium term support offers good timing for purchasing the stock.
  • The company returns high margins, thereby supporting business profitability.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

  • The underlying tendency is negative on the weekly chart below the resistance at 102.75 EUR
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (€)
Sales 2018 39 131 M
EBIT 2018 7 240 M
Net income 2018 4 971 M
Debt 2018 39 542 M
Yield 2018 3,72%
P/E ratio 2018 15,00
P/E ratio 2019 14,06
EV / Sales 2018 2,83x
EV / Sales 2019 2,28x
Capitalization 71 014 M
Surperformance© ratings
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
Bollinger Spread
Unusual Volumes
Duration : Period : Day
Bayer Technical Analysis Chart | MarketScreener
Duration : Period : Week
Bayer Technical Analysis Chart | MarketScreener